Publication: Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE
Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE
Date
Date
Date
Citations
Schreiber, S., Rogler, G., Watanabe, M., Vermeire, S., Maaser, C., Danese, S., Faes, M., Van Hoek, P., Hsieh, J., Moerch, U., Zhou, Y., de Haas, A., Rudolph, C., Oortwijn, A., & Loftus, E. V. (2023). Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE. Alimentary Pharmacology & Therapeutics, 58(9), 874–887. https://doi.org/10.1111/apt.17674
Abstract
Abstract
Abstract
BACKGROUND: Filgotinib 200 mg (FIL200) is an approved treatment for adults with moderately to severely active ulcerative colitis (UC).
AIM: To report integrated safety data from the phase 2b/3 SELECTION study (NCT02914522) and its ongoing long-term extension study SELECTIONLTE (NCT02914535).
METHODS: Safety outcomes were analysed in adults with moderately to severely active UC who received FIL200, filgotinib 100 mg (FIL100) or placebo once daily throughout the 11-week SELECTION induction study, the 47-week SELECTION maintenance stud
Additional indexing
Creators (Authors)
- Schreiber, Stefan
- Rogler, Gerhard
- Watanabe, Mamoru
- Vermeire, Séverine
- Maaser, Christian
- Danese, Silvio
- Faes, Margaux
- Van Hoek, Paul
- Hsieh, Jeremy
- Moerch, Ulrik
- Zhou, Yan
- de Haas, Angela
- Rudolph, Christine
- Oortwijn, Alessandra
- Loftus, Edward V
Journal/Series Title
Journal/Series Title
Journal/Series Title
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
Additional Information
Additional Information
Additional Information
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Citations
Schreiber, S., Rogler, G., Watanabe, M., Vermeire, S., Maaser, C., Danese, S., Faes, M., Van Hoek, P., Hsieh, J., Moerch, U., Zhou, Y., de Haas, A., Rudolph, C., Oortwijn, A., & Loftus, E. V. (2023). Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE. Alimentary Pharmacology & Therapeutics, 58(9), 874–887. https://doi.org/10.1111/apt.17674
